Lapatinib 250mg Tablets – Advanced Targeted Therapy for Breast Cancer
Cordium Pharmaceuticals Pvt Ltd is a leading global exporter of high-quality Lapatinib 250mg Tablets, delivering reliable oncology medicines from India to major international markets including the United States, Germany, United Kingdom, Netherlands, South Africa, United Arab Emirates, and Brazil. With a strong commitment to quality, compliance, and fast logistics, we ensure timely access to life-saving treatments worldwide.
What is Lapatinib 250mg Tablet?
Lapatinib is a targeted therapy medication primarily used in the treatment of HER2-positive breast cancer. It works by blocking specific proteins (HER2 and EGFR) that promote cancer cell growth, thereby slowing or stopping the spread of cancer cells.
Usage of Lapatinib 250mg Tablets
Treatment of advanced or metastatic breast cancer
Used in combination with other medicines like capecitabine or letrozole
Recommended for patients with HER2-positive tumors
Dosage Guidelines
Standard dosage: As prescribed by an oncologist (commonly 1250 mg or 1500 mg daily depending on combination therapy)
Should be taken on an empty stomach, at least 1 hour before or after food
Tablets should be swallowed whole with water
Do not alter dosage without medical advice
Possible Side Effects
Like all medications, Lapatinib may cause side effects. Common ones include:
Diarrhea
Nausea and vomiting
Fatigue
Skin rash
Decreased appetite
Serious side effects (seek medical attention):
Liver problems
Heart rhythm changes
Severe diarrhea or dehydration
Why Choose Cordium Pharmaceuticals Pvt Ltd?
Trusted global exporter of oncology medicines
Strict quality control and international compliance
Fast and secure delivery worldwide
Competitive pricing and reliable supply chain
Dedicated customer support
Global Export & Fast Delivery
We ensure rapid and secure shipping of Lapatinib 250mg Tablets to:
United States | Germany | United Kingdom | Netherlands | South Africa | UAE | Brazil
Contact Us for Bulk Orders & Enquiries
📞 WhatsApp: +91-9405117673
📧 Email: info@cordiumpharma.com
Cordium Pharmaceuticals Pvt Ltd is a leading global exporter of high-quality Lapatinib 250mg Tablets, delivering reliable oncology medicines from India to major international markets including the United States, Germany, United Kingdom, Netherlands, South Africa, United Arab Emirates, and Brazil. With a strong commitment to quality, compliance, and fast logistics, we ensure timely access to life-saving treatments worldwide.
What is Lapatinib 250mg Tablet?
Lapatinib is a targeted therapy medication primarily used in the treatment of HER2-positive breast cancer. It works by blocking specific proteins (HER2 and EGFR) that promote cancer cell growth, thereby slowing or stopping the spread of cancer cells.
Usage of Lapatinib 250mg Tablets
Treatment of advanced or metastatic breast cancer
Used in combination with other medicines like capecitabine or letrozole
Recommended for patients with HER2-positive tumors
Dosage Guidelines
Standard dosage: As prescribed by an oncologist (commonly 1250 mg or 1500 mg daily depending on combination therapy)
Should be taken on an empty stomach, at least 1 hour before or after food
Tablets should be swallowed whole with water
Do not alter dosage without medical advice
Possible Side Effects
Like all medications, Lapatinib may cause side effects. Common ones include:
Diarrhea
Nausea and vomiting
Fatigue
Skin rash
Decreased appetite
Serious side effects (seek medical attention):
Liver problems
Heart rhythm changes
Severe diarrhea or dehydration
Why Choose Cordium Pharmaceuticals Pvt Ltd?
Trusted global exporter of oncology medicines
Strict quality control and international compliance
Fast and secure delivery worldwide
Competitive pricing and reliable supply chain
Dedicated customer support
Global Export & Fast Delivery
We ensure rapid and secure shipping of Lapatinib 250mg Tablets to:
United States | Germany | United Kingdom | Netherlands | South Africa | UAE | Brazil
Contact Us for Bulk Orders & Enquiries
📞 WhatsApp: +91-9405117673
📧 Email: info@cordiumpharma.com
Keywords
